AB4AD AB4AD (Antibodies for Alzheimer's Disease) NO.7461
$0.08
--
24H最低  -- 24H最高  --
更新时间：2025-12-15 00:35:14
OKX欧易app

OKX欧易app

欧易交易所app是全球排名第一的虚拟货币交易所，注册领取6万元盲盒礼包!

APP下载 官网注册
币安APP下载

币安APP下载

币安交易所是世界领先的数字货币交易平台，在手机上即可买卖btc等数字货币！

APP下载 官网注册
暂无数据
火币HTX

火币HTX

全球三大交易所之一，新人注册火币享241 USDT新人礼包！

APP下载 官网注册
时间
涨跌幅
7天
-14.86%
14天
-14.86%
30天
-6.77%
时间
涨跌幅
7天
-14.86%
14天
-14.86%
30天
-6.77%
Ab4AD (Antibodies for Alzheimer’s Disease) is a research initiative from Dr. Daniel Z. Bar (Tel Aviv University) that investigates the pathogen hypothesis of Alzheimer’s: common infections (notably herpes and P. gingivalis) appear to modulate AD risk. The team will analyze blood and saliva from dementia-free elderly individuals and compare them to AD patients and younger controls to identify protective antibodies. Instead of only targeting protein aggregation, Ab4AD focuses on why some exposed individuals stay dementia-free, using their natural antibody profiles as blueprints for protection. Funded and tracked through Molecule Catalyst, enabling visible milestones and community governance via IP Tokens (IPTs).

AB4AD相关讨论

暂无数据